Empagliflozin vs Rosuvastatin

Empagliflozin vs Rosuvastatin: Overview

This comparison examines the pharmacological differences between Empagliflozin and Rosuvastatin.

Mechanism of Action

Empagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption.

Rosuvastatin: Competitive inhibitor of HMG-CoA reductase.

Pharmacokinetics

Half-life: Empagliflozin — 12.4 hours; Rosuvastatin — 19 hours.

Chemical Properties

Molecular Formula: Empagliflozin — C23H27ClO7; Rosuvastatin — C22H28FN3O6S.

Molecular Weight: Empagliflozin — 450.9100 g/mol; Rosuvastatin — 481.5390 g/mol.

Type: Empagliflozin — Small molecule; Rosuvastatin — Small molecule.